Medizinische Universitätsklinik Bochum

DSHNHL 2006-R5 Studie Die Studie wurde geschlossen Open, multicenter, non-randomized phase II study: Evaluation of efficacy,feasibility and toxicity of 4 cycles Rituximab/Gemcitabine/ Oxaliplatin/ Dexamethasone (R-GemOXDex) followed by high-dose chemotherapy with treosulfan/etoposide/ Ara-C (TEA) and autologus stemm cell transplantation in elderly (>=65 years) or medically impaired patients (50-64 years) with relapsed or refractory aggressive Non-Hodgkin's lymphoma